Tian Xiao Zhao (Tian X Zhao, Tian Zhao)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Acute Coronary Syndrome

St Segment Elevation Myocardial Infarction

Top Venues

Journal of the American Heart Association

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Minoru Takaoka, Xiaohui Zhao, Hwee Ying Lim, Costan G Magnussen, Owen Ang, Nadine Suffee, Patricia R Schrank, Wei Siong Ong, Dimitrios Tsiantoulas, Felix Sommer, Sarajo K Mohanta, James Harrison, Yaxing Meng, Ludivine Laurans, Feitong Wu, Yuning Lu, Leanne Masters, Stephen A Newland, Laura Denti, Mingyang Hong, Mouna Chajadine, Markus Juonala, Juhani S Koskinen, Mika Kähönen, Katja Pahkala, Suvi P Rovio, Juha Mykkänen, Russell Thomson, Tsuneyasu Kaisho, Andreas J R Habenicht, Marc Clement, Alain Tedgui, Hafid Ait Oufella, Tian Xiao Zhao, Meritxell Nus, Christiana Ruhrberg, Soraya Taleb, Jesse W Williams, Olli T Raitakari, Veronique Angeli, Ziad Mallat
Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis. Nature (2024)
Akimichi Inaba, Zewen Kelvin Tuong, Tian Xiao Zhao, Andrew P Stewart, Rebeccah Mathews, Lucy Truman, Rouchelle Sriranjan, Jane Kennet, Kourosh Saeb Parsy, Linda S Wicker, Frank Waldron-Lynch, Joseph Cheriyan, John A Todd, Ziad Mallat, Menna R Clatworthy
Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells. Nature communications 14 (1) (2023)
Muhammad Aetesam-Ur-Rahman, Tian Xiao Zhao, Kitty Paques, Joana Oliveira, Bharat Khialani, Stephen Kyranis, Denise M Braganza, Sarah C Clarke, Martin R Bennett, Nick E J West, Stephen P Hoole
Coronary Flow Variations Following Percutaneous Coronary Intervention Affect Diastolic Nonhyperemic Pressure Ratios More Than the Whole Cycle Ratios. Journal of the American Heart Association 11 (9) (2022)
Rouchelle S Sriranjan, Tian Xiao Zhao, Jason Tarkin, Annette Hubsch, Joanna Helmy, Evangelia Vamvaka, Navazh Jalaludeen, Simon Bond, Stephen P Hoole, Philip Knott, Samantha Buckenham, Victoria Warnes, Nick Bird, Heok Cheow, Heike Templin, Paul Cacciottolo, James H F Rudd, Ziad Mallat, Joseph Cheriyan
Low-dose i nterleukin 2 for the reduction of v ascular inflammati o n in acute corona ry syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial. BMJ open 12 (10) (2022)
Tian Xiao Zhao, Ziad Mallat
Adapting treatments for adaptive immunity in ischaemic heart disease. Cardiovascular research 118 (9) (2022)
Tian Xiao Zhao, Michalis Kostapanos, Charmaine Griffiths, Emma L Arbon, Annette Hubsch, Fotini Kaloyirou, Joanna Helmy, Stephen P Hoole, James H F Rudd, Graham Wood, Keith Burling, Simon Bond, Joseph Cheriyan, Ziad Mallat
Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial. BMJ open 8 (9) (2018)